Since CDDO-Me inhibited both p-Akt and p-mTOR in pancreatic cancer cells we determined whether the Akt/mTOR signaling axis regulates response of these cancer cells to CDDO-Me. The gene discussed is AKT1; the disease is pancreatic neoplasm.